Introduction
Adult tissue homeostasis is often maintained by stem cells, which continue to provide new cells in response to cell loss due to either injury or environmental factors (Morrison and Spradling, 2008) . Stem cells are a group of cells capable of self-renewal and producing daughter cells that have the potential to differentiate into specific cell lineages. These cells are regulated by both intrinsic factors and extrinsic signals from the surrounding microenvironment, known as niche. Premature differentiation or defective cell division of stem cells may deplete the stem cell pool and result in tissue atrophy, whereas excessive proliferation or attenuation of differentiation may lead to tumorigenesis. Thus, it is critical to investigate the molecular mechanisms underlying the stem cell regulation.
To dissect signaling pathways that control stem cell properties, such as cell fate specification, Drosophila oogenesis provides a favorable in vivo model (Fig. 1A) . The Drosophila ovary contains germline stem cells (GSCs) and two types of somatic stem cells: follicle stem cells (FSCs) and escort stem cells (Dobens and Raftery, 2000; Horne-Badovinac and Bilder, 2005) . GSCs and FSCs reside in the germarium, a structure located at the anterior tip of the ovary (Fuller and Spradling, 2007; Kirilly and Xie, 2007) . Each germarium generally contains two to three GSCs that continue to divide and give rise to cystoblasts, which then divide four times synchronously with incomplete cytokinesis to form 16-cell germline cysts. As germline cysts move posteriorly, they are wrapped by follicle cells derived from the FSCs and bud off from the germarium to form individual egg chambers. Two FSCs are located on the opposite sides in the halfway point of the germarium (Margolis and Spradling, 1995; Nystul and Spradling, 2010) . Each FSC divides and gives rise to two daughter cells: one daughter cell retains its stem cell properties and stays in the niche, while the other daughter cell proliferates and generates multiple follicle cell precursors. These follicle cell precursors differentiate into three types of follicle cells: main-body follicle cells, polar cells, and stalk cells. Polar cells are pairs of specialized follicle cells located at each pole of the egg chamber, whereas five to eight stalk cells separate adjacent egg chambers. Main-body follicle cells continue to proliferate and form an epithelial cell layer surrounding the egg chamber. Proper specification of these three types of cells allows correct egg chamber formation (Horne-Badovinac and Bilder, 2005) .
Different follicular cell types are specified by coordination of multiple signaling pathways. In the germarium or stage 1-2 egg chambers, germline cells secrete Delta (Dl), which activates Notch signaling in some follicle cell precursors and specifies these cells into polar cells. Mutation of Dl in the germline cells or mutation of Notch in the follicle cell precursors results in loss of polar cells, leading to egg chamber fusion (Lopez-Schier and St Johnston, 2001; Torres et al., 2003) . Similarly, follicle cell precursors mutant for fringe (fng), a positive regulator of Notch signaling, also fail to differentiate into polar cells (Grammont and Irvine, 2001 ). Over-expression of an active form of Notch driven by either c306-Gal4 (see below) or heatshockGal4 increases numbers of polar cells and stalk cells (Larkin et al., 1996; Shyu et al., 2009) . Once polar cells are specified, they secrete Dl and Unpaired (Upd), the JAK/STAT pathway ligand, that subsequently induce adjacent follicle cell precursors to differentiate into stalk cells The germarium is divided into four regions. In region 1, germline stem cells (purple) divide and generate cystoblasts, which undergo four times of cell division with incomplete cytokinesis to form 16-cell cysts. Two follicle stem cells (FSCs, orange) are located at the border of regions 2a and 2b. When a cyst has reached region 2b, follicle cell precursors (yellow) produced by FSCs migrate between successive egg chambers and begin to intercalate, causing the region 3 egg chamber to be separated from the germarium. These follicle cell precursors are then specified into polar cells (red), main-body follicle cells (gray), and stalk cells (green). Follicle cell precursors and polar cells were labeled by anti-FasIII antibody in (B-F). Cell nuclei were stained by DAPI in (B-F). (B, C) The expression pattern of Yki in heterozygous FRT42D yki B5 ovaries. Yki was not detected in a homozygous yki mutant cell (GFP-negative) circled by yellow dashed lines. Follicle cell precursors and polar cells with a low level of Yki nuclear distribution are indicated by yellow arrows and yellow arrowheads, respectively. (D) c306-Gal4 was used to drive GFP expression from a UAS-GFP transgene. GFP was expressed at high level in all follicle cell precursors in the germarium (yellow bracket) and polar cells (yellow arrowheads), but lower in the main-body follicle surrounding polar cells. (E) Expression of yki-S111A, S168A, S250A with c306-Gal4 driver. Polar cells and stalk cells were not properly formed between egg chambers (white bracket) and egg chambers fused together. (F) Knockdown of yki in follicle cell precursors by a RNAi line P{KK109756}v104523 using c306-Gal4 driver. Numbers of FasIII-positive cells were increased (white brackets). Numbers of main-body follicle cells were decreased and egg chambers were not fully covered by main-body follicle cells (white dashed lines). Length of scale bars is 10 μm for all panels.
(Assa- Kunik et al., 2007; McGregor et al., 2002) . Thus, the specification of stalk cells requires signals released from the polar cells. Besides Notch, the Hedgehog (Hh) signaling also regulates polar cell formation. Over-activation of the Hh pathway delays follicle cell differentiation and causes an increase in the number of polar cells (Forbes et al., 1996; Tworoger et al., 1999; Zhang and Kalderon, 2000) . This ectopic polar cell formation is caused by an inhibition of Eyes absent (Eya), a tyrosine phosphatase and transcriptional co-activator that represses polar cell fate (Bai and Montell, 2002) . Furthermore, a downstream effector of the Notch signaling Extra macrochaetae (Emc) also regulates follicle cell fate by repressing eya expression (Adam and Montell, 2004) . While interplay among these signaling pathways specifies different types of follicle cells, other signaling pathways participating in this process remain to be elucidated. The Hippo pathway is recently identified to play important roles in cell proliferation and organ size control (Camargo et al., 2007; Halder and Johnson, 2011; Harvey and Tapon, 2007; Lian et al., 2010; Lu et al., 2010; Oh and Irvine, 2010; Pan, 2010; Saucedo and Edgar, 2007; Song et al., 2010; Zhang et al., 2009 Zhang et al., , 2010 . The core components of the Hippo pathway are Hippo (Hpo), Warts (Wts), Salvador (Sav), Mob as a tumor suppressor (Mats), and Yorkie (Yki). Hpo is an Ste20-like kinase that forms a complex with the adaptor protein Sav and phosphorylates Wts, a nuclear Dbf2-related (NDR) family kinase (Harvey et al., 2003; Justice et al., 1995; Pantalacci et al., 2003; Udan et al., 2003; Watson, 1995; Wu et al., 2003) . In association with the adapter protein Mats (Lai et al., 2005) , Wts phosphorylates Yki, a transcriptional co-activator (Huang et al., 2005; Wei et al., 2007) . Phosphorylated Yki interacts with 14-3-3 phosphopeptide binding protein, resulting in a retention of Yki in the cytoplasm and repression of its transcriptional activity (Dong et al., 2007; Huang et al., 2005; Oh and Irvine, 2008; Ren et al., 2010b) . When Yki is not phosphorylated, it is localized to the nucleus and interacts with transcription factors such as Scalloped (Sd) to activate target gene expression. Most identified target genes of Yki, such as cyclin E, Myc, diap, and bantam, promote cell proliferation or cell survival (Goulev et al., 2008; Wu et al., 2008; Zhang et al., 2008; Zhao et al., 2008; Ziosi et al., 2010) . For the upstream regulators, Merlin (Mer) and Expanded (Ex), two FERM domain-containing family proteins, as well as the WW and C2 domain-containing protein Kibra, interact with the Hippo kinase cascade and activate Wts (Baumgartner et al., 2010; Genevet et al., 2010; Hamaratoglu et al., 2006; McCartney et al., 2000; Yu et al., 2010) . Mediators of the planar cell polarity, such as the atypical cadherin Fat (Ft) and the unconventional myosin Dachs, also influence the Hippo pathway (Bennett and Harvey, 2006; Cho et al., 2006; Silva et al., 2006; Tyler and Baker, 2007; Willecke et al., 2006 Willecke et al., , 2008 Zecca and Struhl, 2010) . All components of the Hippo pathway are highly conserved from Drosophila to mammals, suggesting that this pathway is essential for cellular functions in a variety of organisms (Badouel et al., 2009; Chan et al., 2010; Durrheim and Leggat, 1999; Harvey and Tapon, 2007; Pan, 2010; Zeng and Hong, 2008) . Recently, the Hippo pathway has also been shown to control proliferation and differentiation potential of stem cells. In Drosophila intestinal stem cells, the Hippo pathway is required for stem cell division in response to tissue damage through the JAK/STAT and EGFR signaling pathways (Karpowicz et al., 2010; Ren et al., 2010a; Shaw et al., 2010; Staley and Irvine, 2010) . Consistent with the findings in Drosophila, the Hippo pathway controls cell proliferation and differentiation of liver progenitor/stem cells in mice (Camargo et al., 2007; Lu et al., 2010; Song et al., 2010; Zhang et al., 2010) . Furthermore, the mammalian homolog of Yki, YAP, is inactivated during embryonic stem (ES) cell differentiation. Knockdown of YAP leads to a loss of ES cell pluripotency, while overexpression of YAP prevents ES cell differentiation (Lian et al., 2010) . While the roles of the Hippo pathway in regulating stem cell properties are emerging, whether the Hippo pathway controls other developmental processes remains to be explored.
Here, we report that the Hippo pathway participates in polar cell fate determination in the Drosophila ovary. Yki is excluded from the nuclei of some follicle cell precursors and polar cells, suggesting that Yki activity is suppressed during polar cell specification. Overactivation of Yki leads to egg chamber fusion and defective polar cell and stalk cell formation. By using both RNAi and clonal analysis approaches, we find that follicle cells with reduced or lacking yki expression differentiate into polar cells. Consistently, polar cells with either hpo or wts mutations are not specified properly. Furthermore, Yki suppresses polar cell fate through inhibiting Notch activity. Our results have revealed a novel role of the Hippo pathway in cell fate specification and increase understanding of how signaling pathways interplay to determine cell fate.
Materials and methods

Fly stocks
The fly stocks for RNAi and Yki immunostaining experiments were (Dietzl et al., 2007) /TM3 and ey-flp; FRT82B (Xu and Rubin, 1993) .
Over-expression of yki and RNAi experiments
Flies were cultured at 18°C before eclosion. Newly eclosed adult flies were collected and grown at 30°C for 5-6 days before dissection.
Generation of mitotic clones
The FLP/FRP site-specific recombination system was used to generate mutant clones with a heatshock promoter (Xu and Rubin, 1993) . Newly eclosed flies were collected for two consecutive days, then heatshocked at 37°C four times over the next two days. On the first day they were heatshocked twice for 30 min each with a fourhour interval between heatshocks. On the second day they were heatshocked once for 30 min then once for 1 h. All flies were incubated at 25°C for six days before dissection.
Antibodies
The following antibodies were used: mouse anti-Fasciclin III [7G10, Developmental Studies Hybridoma Bank (DSHB)], mouse anti-β-Galactosidase (40-1A, DSHB), mouse anti-Notch intracellular domain (C17.9C6, DSHB), mouse anti-Eya (eya10H6, DSHB), rabbit anti-GFP (Invitrogen, Carlsbad, CA, USA), rabbit anti-β-Galactosidase (Millipore, Billerica, MA, USA), Dylight-488 goat anti-rabbit IgG(H + L), Dylight-549 goat anti-mouse IgG(H+ L) (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA, USA), and Alexa Fluor 633 goat anti-mouse IgG (H+ L) (Invitrogen, Carlsbad, CA, USA), anti-Yki (provided by Dr. Kenneth D. Irvine, Rutgers University).
Immunostaining and fluorescence microscopy
Ovaries were dissected at six days after heatshock in phosphatebuffered saline (PBS) and fixed in 4% paraformaldehyde (PFA) in PBS. After fixation, ovaries were rinsed with PBT (1XPBS, and 0.2% Triton X-100) followed by incubation in the blocking solution PBTB (1XPBS, 0.5% Triton X-100, 5% goat serum, 2.5 mg/ml BSA, and 0.05% Sodium azide). Ovaries were then incubated with the primary antibodies overnight at 4°C, washed with PBT, and followed by secondary antibody staining. Ovaries were further stained with DAPI in PBT (1 μg/ml, Sigma) prior to mounting with mounting solution [85% glycerol, 1XPBS, 3% propyl gallate (Sigma), and ProLong® Gold Antifade reagents (Invitrogen, Carlsbad, CA, USA)]. Images were taken by confocal microscopies including Leica TCS SP2 (Leica Microsystems GmbH, Germany), Olympus FV1000 (Olympus Corporation, Japan), and Zeiss LSM700 (Carl Zeiss AG, Germany). The images were processed in Adobe Photoshop CS3 (San Jose, CA, USA). Signal intensities for β-Galactosidase of A101 were quantified using ImageJ (National Institute of Health, Bethesda, Maryland, USA).
Results
To explore roles of the Hippo pathway during Drosophila oogenesis, we examined the expression pattern and cellular localization of Yki. First, we showed the specificity of the Yki antibody in the Drosophila ovary by staining of yki mutant clones. These yki mutant clones were generated by mitotic recombination with a yki amorph, yki B5 (Xu and Rubin, 1993) . The absence of anti-Yki staining in yki mutant follicle cell clones demonstrated that the antibody specifically recognizes Yki (Fig. 1B) . Yki was not detected in germline cells, which is consistent with previous findings that the Hippo pathway is dispensable in germline cells (Shcherbata et al., 2007; Sun et al., 2008) . On the other hand, Yki was detected in most follicle cells (Figs. 1B, C). To distinguish different follicle cell types, we stained the ovaries with an antibody against Fasciclin III (FasIII), which labels follicle cell precursors in the germarium and polar cells in developing egg chambers (Figs. 1B,C) (Ruohola et al., 1991) . The immunostaining results showed that Yki is expressed in follicle cell precursors, mainbody follicle cells, and polar cells (Figs. 1B, C) . Interestingly, despite its function as transcriptional co-activator, subcellular localization of Yki is restricted to the cytoplasm in polar cells in stage 2-3 egg chambers (Figs. 1B, C) . This restriction is also observed in some follicle cell precursors located at the boundary between germarium regions 2b and 3, where polar cells are presumably specified (Fig. 1C ) (Nystul and Spradling, 2010) . Since nuclear localization is necessary for its transcriptional activity, exclusion of Yki from the nucleus suggests that Yki activity prevents follicle cell precursors to differentiate into polar cells.
To test this hypothesis, we first over-expressed wild-type yki, yki-S168A, and yki-S111A, S168A, S250A in follicle cell precursors and examined polar cell formation. Ser residues at positions 111, 168, and 250 of Yki are phosphorylated by Wts and the phosphorylation prevents its nuclear localization. The Ser168 to Ala mutation of Yki reduces, but not eliminates the regulation by Wts. The Ser 111, 168, 250 to Ala mutation of Yki stays in the nucleus to activate expression of downstream targets Irvine, 2008, 2009 ). Expression of wild-type or mutant yki was driven with a c306-Gal4 line (Manseau et al., 1997) . The c306-Gal4 line was first crossed with a UAS-GFP line and the result demonstrated that c306-Gal4 is expressed in all follicle cell precursors in the germarium (Fig. 1D) . In egg chambers from stage 3 onward, GFP was detected at a high level in polar cells and lower in the main-body follicle cells surrounding polar cells (Fig. 1D) . Over-expression of the constitutively active yki-S111A, S168A, S250A in follicle cell precursors resulted in egg chamber fusion (Fig. 1E and Fig. S1C in the Supplementary Data; 91.7%, n = 192), possibly due to the loss of polar cells and stalk cells. Over-expression of yki or yki-S168A did not affect polar cell differentiation and the exogenous Yki remained in the cytoplasm (Fig. S1A, B; n N 20), suggesting that Yki localization and activity is regulated in the polar cells. Knockdown of yki in follicle cell precursors with c306-Gal4 and an RNAi line P {KK109756}v104523 led to an increase in the number of FasIIIexpressing cells in stage 2-5 egg chambers ( Fig. 1F; n N 20) . These excessive FasIII-positive cells were morphologically similar to polar cells in stage 6 egg chambers (Fig. S2A) . The same phenotypes were observed in another RNAi line P{GD11187}v40497 (Fig. S2B and data not shown), suggesting that the phenotypes were not resulted from off-target effects of RNAi. In addition to the extra polar cells, many egg chambers were not fully encapsulated by main-body follicle cells (Fig. 1F and Fig. S2 ). These results suggested that most yki-knocked down follicle cell precursors differentiated into polar cells at the expense of the follicle cell precursors that were supposed to differentiate into main-body follicle cells.
To further explore whether reduction of Yki is sufficient to specify polar cells, we generated yki B5 mutant clones. FRT42D clones were generated as a control. In the control group, GFP-negative clones contained both polar cells and main-body follicle cells, indicating that follicle cell precursors can differentiate into both cell types ( Fig. 2A ; n N 20). Most yki mutant cells expressed FasIII in the same pattern and intensity as polar cells even in an egg chamber that already contained two pairs of polar cells ( Fig. 2B ; 76.7%, n = 43). To confirm if these ectopic FasIII-positive cells had similar or the same properties as polar cells, we used an enhancer trap line A101 (neuralized-lacZ), whose lacZ is expressed exclusively in polar cells ( Fig. 2C ; n = 8) (Bellen et al., 1989; Lopez-Schier and St Johnston, 2001 ). In most yki mutant cells, β-Galactosidase (β-Gal) was detected ( Fig. 2D ; 95.9%, n = 49), suggesting that these yki mutant cells were indeed polar cells. We further examined the expression of eya, which should be in the mainbody follicle cells but absence from polar cells (Bai and Montell, 2002) . yki mutant cells showed reduced or absence of Eya (Figs. 2E, F; 34.8%, n = 69). In consistent with the findings from our RNAi experiments, these results demonstrated that yki mutant cells differentiated into polar cells in a cell-autonomous manner. Because Hpo and Wts are negative regulators of Yki, their effects on polar cell fate should be opposite to that of Yki. To examine such effects, we generated mutant clones with loss-of-function allele hpo [42] [43] [44] [45] [46] [47] or wts 3-17 . We specifically analyzed those pairs of polar cells with one GFP-negative hpo or wts mutant polar cell and one GFPpositive control polar cell (Figs. 3A-F) . hpo or wts mutant polar cells expressed less FasIII or A101-β-Gal in comparison with the adjacent control polar cells (Figs. 3A-F; reduced FasIII staining in hpo: 85.7%, n = 21; reduced A101-β-Gal: 75%, n = 20; reduced FasIII staining in wts: 61.5%, n = 13). In A101-lacZ background, the β-Gal staining intensity in hpo mutant polar cells was reduced to 58% of that in the adjacent control polar cells (Fig. S3) . The same phenotypes were observed when loss-of-function allele hpo KC202 or wts X1 was used (data not shown). In addition, low levels of both the polar cell marker A101 and the main-body follicle cell marker Eya were detected simultaneously in hpo mutant polar cells (Figs. 3G, H) . Together, these results suggested that polar cell fate in hpo or wts mutant cells are not properly specified. It has been shown that polar cells are required for the formation of stalk cells to separate individual egg chambers. Without stalk cells, egg chambers are fused (Assa-Kunik et al., 2007) . In the ovarioles where most of the follicle cells were mutant for hpo or wts, we observed fused egg chambers (Fig. 4 ; hpo and wts: n N 10). hpodeficient polar cells expressing both the main-body follicle cell marker Eya and the polar cell marker A101-β-Gal were found near the middle of the fused egg chamber (Fig. 4A) . Some fused egg chambers did not contain any A101-β-Gal-or FasIII-positive or Eya-negative polar cells in the middle and had a single or double-layer of follicle cells between them (Figs. 4B-E) . These results further suggest that Hpo or Wts is required for polar cell specification, possibly through inactivation of Yki as the canonical Hippo pathway. Indeed, Yki appeared to distribute throughout the nucleus and cytoplasm in wts mutant polar cells (Fig. S4) , supporting that Wts affects polar cell formation via cytoplasmic retention of Yki by phosphorylation. We further tested if other components of the Hippo pathway influence polar cell specification. For the upstream components ex, Mer, kibra, fat, and dachs, only kibra mutant polar cells expressed less FasIII ( Fig. S5C ; n = 5), while polar cells mutant for ex, Mer, fat, or dachs were indistinguishable from control polar cells ( Fig. S6B-E; n N 10 ). Sd is a transcription factor interacting with Yki (Wu et al., 2008; Zhang et al., 2008) . Cells mutant for sd expressed FasIII (Fig. S5B; 94 .6%, n = 37), suggesting that these cells differentiated into ectopic polar cells, which is similar to yki mutant cells. Interestingly, while the mats mutant cells failed differentiate into polar cells and led to egg chamber fusion ( Fig. S5D ; n = 26), mutation of sav did not affect polar cell specification ( Fig. S6F; n N 20) .
Loss of Notch activity in the follicle cells results in no polar cells and egg chamber fusion (Grammont and Irvine, 2001; Lopez-Schier and St Johnston, 2001) , which is similar to the phenotypes of hpo or wts mutants. Over-activation of Notch, on the other hand, increases polar cell numbers, which is similar to the phenotypes of yki mutants (Assa-Kunik et al., 2007; Larkin et al., 1996; Shyu et al., 2009) . Therefore, we hypothesized that the Hippo pathway regulates polar cell fate through Notch signaling. To test if the Hippo pathway affects Notch signaling, we generated FRT42D control clones or yki B5 mutant clones in a Notch activity reporter line, Gbe-Su(H) lacZ. The lacZ expression was increased in polar cells and yki mutant follicle cells (Figs. 5A, B; FRT42D clones: 13.5% contained cells with increased lacZ expression levels, n = 52; yki: 68.5%, n = 54), indicating that the Notch pathway was activated. This result suggested that yki represses Notch activity. If yki suppresses polar cell fate by inhibiting Notch activity, reduction of Notch in yki mutant cells should attenuate ectopic polar cell formation resulted from yki mutation. yki B5 mutant clones were generated in either a wild-type Notch background or a heterozygous background for a Notch amorph, N 55e11
. While yki mutant cells differentiated into polar cells expressing high levels of FasIII in the wild-type Notch background ( Fig. 5C ; n = 7), yki mutant cells in the reduced Notch background expressed less FasIII ( Fig. 5D ; 88.5% of the clones with reduced FasIII levels, n = 26). These results support our hypothesis that the Hippo pathway acts upstream of Notch in polar cell specification (Fig. 5E ).
Discussion
In this study, we identify a novel role of the Hippo pathway: cell fate specification during Drosophila oogenesis. yki mutant cells differentiate into polar cells in a cell-autonomous manner; hpo or wts mutant cells do not differentiate into polar cells properly. Our results demonstrate that hpo/wts and yki play opposite roles in polar cell formation, and yki represses polar cell fate. Furthermore, yki inhibits Notch activity, and reduction of Notch activity attenuates the polar cell specification phenotype in yki mutant cells. Taken together, we propose that Hpo and Wts regulate the activity of Yki in the follicle cell precursors. Inactivation of Yki leads to up-regulation of Notch activity, thereby specifying polar cell fate. On the other hand, increase of Yki activity promotes follicle cell precursors to differentiate into main-body follicle cells (Fig. 5E) .
In addition to hpo, wts, and yki, we have examined effects of other Hippo pathway components on polar cell specification during early oogenesis (Figs. S5, 6 ). Most upstream components, including ex, Mer, fat, and dachs, do not affect polar cell determination individually. A possibility is that they act redundantly to activate the Hippo pathway (Hamaratoglu et al., 2006) . Therefore, mutation of individual upstream regulators is insufficient to inhibit the Hippo pathway activity thoroughly. Alternatively, the Hippo pathway may be influenced under different signalings in the follicle cells during early oogenesis.
Under the control of both extrinsic and intrinsic signals, follicle cell precursors differentiate into polar cells, main-body follicle cells, or stalk cells. Polar cells exist from cell cycle soon after cell fate specification (Nystul and Spradling, 2010) . Mis-expression of String, a Drosophila Cdc25-type phosphatase, with c306-Gal4 driver in polar cells triggers polar cell proliferation and increases polar cell numbers (Shyu et al., 2009) . Therefore, an increase of polar cells can be resulted from either proliferation of polar cells or fate change of other cells that are not supposed to differentiate into polar cells. When we knocked down yki in follicle cell precursors with c306-Gal4, we observed an increase of FasIII-positive cells, presumably polar cells (Figs. 1F, S2 ). Since c306-Gal4 is expressed in almost all follicle cell precursors (Fig. 1D) , it is likely that yki reduction promotes most of them to differentiate into polar cells. Because few follicle cell precursors are left to differentiate into main-body follicle cells, egg chambers are not thoroughly enwrapped. It is less likely that knockdown of yki promotes polar cell proliferation because yki mutant clones usually contain only one to two polar cells (Figs. 2B, D, F) , suggesting that reduction of yki specify polar cell fate and these cells withdraw from cell cycle immediately. Previous studies have shown interactions between the Hippo pathway and Notch signaling in Drosophila. Hippo pathway controls endocytosis of Notch. Mer and Ex are two upstream components that promote activation and phosphorylation of Hpo. In Mer ex double mutant cells on the wing or eye imaginal discs, Notch levels are upregulated at the plasma membrane due to a defect in receptor clearance from the cell surface. A slight increase in Notch activity is observed in these Mer ex double mutant cells (Maitra et al., 2006) . Disruption of hpo or sav also leads to abnormal accumulation and distribution of Notch in the posterior follicle cells in stage 7-10 egg chambers (Yu et al., 2008) . However, Notch activity is attenuated in these hpo or sav mutant cells (Meignin et al., 2007; Polesello and Tapon, 2007; Yu et al., 2008) . Despite the discrepancy in different tissues, most findings indicate that the Hippo pathway regulates Notch signaling through receptor processing or localization. In our study, we also observed that yki regulates Notch activity as well as a genetic interaction between yki and Notch in polar cell specification during early oogenesis. However, the expression level and pattern of Notch are not changed in yki, hpo, or wts mutant clones in early stage egg chambers based on immunofluorescence results with an antibody against the Notch intracellular domain (NICD) (Fig. S7) . How the Hippo pathway controls Notch activity during polar cell specification remains to be investigated.
Besides Notch, the Hh signaling also regulates polar cell formation. Over-activation of the Hh pathway delays follicle cell differentiation and causes an increase in the number of polar cells (Forbes et al., 1996; Tworoger et al., 1999; Zhang and Kalderon, 2000) . We have tested if the Hippo pathway affects the Hh signaling by using a ptc-lacZ reporter line during polar cell specification. lacZ expression was not affected in wts mutant clones during polar cell specification in the germarium region 3 ( Fig. S8 ; n N 10), suggesting that the Hh signaling does not act downstream of the Hippo pathway in polar cell specification. Further experiments are required to examine if the Hippo pathway interacts with other signaling pathways during polar cell formation. Eyes absent (Eya) is a transcriptional co-activator and a protein tyrosine phosphatase required for the formation and specification of not only the Drosophila eyes but also many other tissues in a variety of organisms (Jemc and Rebay, 2007) . During Drosophila oogenesis, Eya is a critical repressor of polar cell fate. Eya is present in follicle cell precursors and main-body follicle cells, but not in polar cells. Loss of eya induces ectopic polar cells in a cell-autonomous manner, which is similar to the phenotypes of yki mutant cells (Bai and Montell, 2002) . Furthermore, the Notch pathway acts upstream of eya. Because Eya is reduced or absent in yki mutant clones and up-regulated in hpo mutant polar cells (Figs. 2F, 3H, 4E) , it is likely that yki functions upstream of eya and controls eya expression through the Notch signaling.
In Drosophila, the Hippo pathway components hpo, wts, and sav have been shown to define the R8 photoreceptor cell fate (MikeladzeDvali et al., 2005) . Here, we find that hpo, wts, and yki are critical for polar cell specification during oogenesis. Whether the Hippo pathway controls cell fate in other tissues in Drosophila or in different organisms remains to be explored. While most identified downstream targets of yki, such as diap, cycE, bantam, dMyc, and expanded, are all involved in cell cycle regulation or cell survival, it would be important to identify new yki downstream target genes that participate in cell fate determination. Our findings contribute to the understanding of molecular mechanisms controlling cell fate determination and provide new insights of the pleiotropic Hippo pathway.
